Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 478 participants.

Also called NCT01453582

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 478 participants (enrolled count) (from the registry)
Sponsor
Shanghai Greenvalley Pharmaceutical Co., Ltd. (from the registry)
Registry
  • NCT NCT01453582
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01453582. Randomized; double masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris
Condition
Stable Angina Pectoris
Intervention (Drug)
Total Flavonoids of Propolis dropping pill
Intervention (Drug)
total Flavonoids of Propolis dropping pill
Lead sponsor
Shanghai Greenvalley Pharmaceutical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01453582
Content hash
6f1d715339a7340640872ea381efebeb16e445cf55618d22a7b0f81935527a4b